deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT07444294

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

A Phase 1 Single- and Multiple-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRK-439 in Healthy Adults

Sponsor: Scholar Rock, Inc.

Conditions Healthy
Interventions Placebo SRK-439
Updated 1 time since 2026 Last updated: Feb 24, 2026 Started: Nov 21, 2025 Primary completion: Dec 17, 2026 Completion: Jun 9, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is actively recruiting participants. The trial is conducted by Scholar Rock, Inc. and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

1 version recorded
Recruiting — PHASE1 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Scholar Rock, Inc.
Data source: Scholar Rock, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations